Cat.#: ACPP-1272
| Despition | Bestrophin Blocking Peptide for Immunodepletion, Immunocompetition |
| SIZE | 250 µg |
| Applications | Immunodepletion & Immunocompetition assay |
| Storage | Store at -20⁰C for long term |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1059 | Recombinant Human ALK Protein (Fc Tag) (AC1059) | 50 µg | inquiry |
| ACPP-1836 | Human CHGA Protein (AC1836) | 5 µg | inquiry |
| ACPP-1545 | Human YWHAG Protein (AC1545) | 5 µg | inquiry |
| ACPP-1725 | Human GHRL Protein (AC1725) | 1 mg | inquiry |
| ACPP-1366 | Dopamine D5 Receptor Blocking Peptide (AC1366) | 250 µg | inquiry |
| ACPP-1238 | LIMK1 Blocking Peptide (AC1238) | 250 µg | inquiry |
| ACPP-1203 | ADCY8 Blocking Peptide (AC1203) | 250 µg | inquiry |
| ACPP-1221 | Bestrophin Blocking Peptide (AC1221) | 250 µg | inquiry |
| ACPP-1479 | Human TIMP1 Protein, HEK (AC1479) | 2 µg | inquiry |
| ACPP-1305 | Aph 1b Blocking Peptide (AC1305) | 250 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.